Multivalent structure of galectin-1-nanogold complex serves as potential therapeutics for rheumatoid arthritis by enhancing receptor clustering

Multivalent structure of galectin-1-nanogold complex serves as potential therapeutics for rheumatoid arthritis by enhancing receptor clustering

Cellular behaviour is controlled by numerous processes, including intracellular signalling pathways that are triggered by the binding of ligands with cell surface receptors. Multivalent ligands have multiple copies of a recognition element that binds to receptors and influences downstream signals. N...

Descripció completa

Dades bibliogràfiques
Autors principals:	Y-J Huang, A-L Shiau, S-Y Chen, Y-L Chen, C-R Wang, C-Y Tsai, M-Y Chang, Y-T Li, C-H Leu, C-L Wu
Format:	Article
Idioma:	English
Publicat:	Forum Multimedia Publishing LLC 2012-03-01
Col·lecció:	European Cells & Materials
Matèries:	Rheumatoid arthritis ankle joint apoptosis cell-surface receptors galectin-1 gold inflammation nanoparticles
Accés en línia:	http://www.ecmjournal.org/journal/papers/vol023/pdf/v023a13.pdf

Ítems similars

Clinical Relevance of Galectin-1 and Galectin-3 in Rheumatoid Arthritis Patients: Differential Regulation and Correlation With Disease Activity
per: Santiago P. Mendez-Huergo, et al.
Publicat: (2019-01-01)

Galectin-3 and its correlation with carotid ultrasound in rheumatoid arthritis patients
per: Arwa S. Amer, et al.
Publicat: (2023-12-01)

Increased Galectin-9 Levels Correlate with Disease Activity in Patients with DMARD-Naïve Rheumatoid Arthritis and Modulate the Secretion of MCP-1 and IL-6 from Synovial Fibroblasts
per: Morten A. Nielsen, et al.
Publicat: (2023-01-01)

The Role of Galectin-3 in The Diagnosis and Evaluation of Disease Activity in Rheumatoid Arthritis
per: Shihab Mahmood Almurshedi, et al.
Publicat: (2023-08-01)

Galectin-9 as an indicator of functional limitations and radiographic joint damage in patients with rheumatoid arthritis
per: Jiewen Guo, et al.
Publicat: (2024-06-01)

Ankle arthrodesis in rheumatoid arthritis
per: Vladimir Grigor'evich Fedorov, et al.
Publicat: (2011-02-01)

CLINICAL AND ULTRASOUND ANKLE INVOLVEMENT IN RHEUMATOID ARTHRITIS IN REMISSION
per: Luminita Enache, et al.
Publicat: (2019-06-01)

Apoptosis as a target for gene therapy in rheumatoid arthritis
per: Gabriel Adrián Rabinovich
Publicat: (2000-01-01)

ANKLE ULTRASOUND TENOSYNOVITIS IS A SIGNIFICANT PREDICTOR OF DAS28 – DEFINED RHEUMATOID ARTHRITIS ACTIVITY
per: Luminita Enache, et al.
Publicat: (2019-09-01)

A study of the association between Galectin-9 gene (LGALS9) polymorphisms and rheumatoid arthritis in Egyptian patients
per: Seham Gouda Ameen, et al.
Publicat: (2023-07-01)

Differential regulation and correlation between galectin-9 and anti-CCP antibody (ACPA) in rheumatoid arthritis patients
per: Yuya Fujita, et al.
Publicat: (2020-04-01)

Increased galectin-3 may serve as a serologic signature of pre-rheumatoid arthritis while markers of synovitis and cartilage do not differ between early undifferentiated arthritis subsets
per: Saida Farah Issa, et al.
Publicat: (2017-04-01)

RESULTS OF USING THE MAGGIC HEART FAILURE RISK SCORE AND GALECTIN-3 LEVELS IN ASSESSING MORTALITY RISK IN PATIENTS WITH CHRONIC HEART FAILURE AND RHEUMATOID ARTHRITIS
per: Andrey S. Ankudinov
Publicat: (2024-12-01)

PRP as a modulator of inflammation in FLS of RA patients by regulation of galectins and TGF-β1
per: Shourangiz Piramoon, et al.
Publicat: (2024-01-01)

Immunological assessment of myocardial fibrosis in patients with chronic heart failure associated with rheumatoid arthritis
per: A.S. Ankudinov, et al.
Publicat: (2021-03-01)

Risk Factors Analysis for the Development of Hypocomplementemia in Rheumatoid Arthritis Patients: A Single-Center Retrospective Study
per: Chen Y, et al.
Publicat: (2023-08-01)

Multivalent Lactose–Ferrocene Conjugates Based on Poly (Amido Amine) Dendrimers and Gold Nanoparticles as Electrochemical Probes for Sensing Galectin-3
per: Manuel C. Martos-Maldonado, et al.
Publicat: (2020-01-01)

Glycodendrimers and Modified ELISAs: Tools to Elucidate Multivalent Interactions of Galectins 1 and 3
per: Mark Wolfenden, et al.
Publicat: (2015-04-01)

Pharmacological Aspects of Natural Quercetin in Rheumatoid Arthritis
per: Tang M, et al.
Publicat: (2022-06-01)

Galectin-3 Decreases 4-1BBL Bioactivity by Crosslinking Soluble and Membrane Expressed 4-1BB
per: Morten Aagaard Nielsen, et al.
Publicat: (2022-06-01)

Lymphocyte activation gene 3 is increased and affects cytokine production in rheumatoid arthritis
per: Janni Maria Pedersen, et al.
Publicat: (2023-06-01)

Programmed Cell Death in Rheumatoid Arthritis
per: Tong L, et al.
Publicat: (2025-02-01)

Do ankle, hindfoot, and heel ultrasound findings predict the symptomatology and quality of life in rheumatoid arthritis patients?
per: Șerban Oana, et al.
Publicat: (2020-01-01)

Infliximab in the therapy of rheumatoid arthritis
per: G. V. Lukina, et al.
Publicat: (2016-05-01)

Glycodendrimers: tools to explore multivalent galectin-1 interactions
per: Jonathan M. Cousin, et al.
Publicat: (2015-05-01)

Significance of magnetic resonance imaging for early rheumatoid arthritis activity
per: E Y Pogozeva
Publicat: (2009-02-01)

Rheumatoid Arthritis and the Ankle-Brachial Pressure Index: Any Association?
per: Asso Fraidoon, et al.
Publicat: (2014-02-01)

Rheumatoid Arthritis
per: Mahmood M.T.M. Ally, et al.
Publicat: (2016-03-01)

Effect of high-intensity interval training on muscle remodeling in rheumatoid arthritis compared to prediabetes
per: Brian J. Andonian, et al.
Publicat: (2018-12-01)

The Effects and Potential Mechanisms of Moxibustion for Rheumatoid Arthritis-Related Pain: A Randomized, Controlled Trial
per: Liao C, et al.
Publicat: (2023-05-01)

Significant association of elevated serum galectin-9 levels with the development of non-alcoholic fatty liver disease in patients with rheumatoid arthritis
per: Po-Ku Chen, et al.
Publicat: (2024-02-01)

Rheumatoid arthritis and pseudo-vesicular skin plaques: rheumatoid neutrophilic dermatosis
per: Juan Manriquez, et al.
Publicat: (2016-08-01)

Multivalent scaffolds induce galectin-3 aggregation into nanoparticles
per: Candace K. Goodman, et al.
Publicat: (2014-07-01)

Clinical manifestations of keratitis and corneal ulcers in patients with rheumatoid arthritis: a retrospective analysis
per: L. Y. Riazanova, et al.
Publicat: (2022-10-01)

PSYCHOPHYSIOLOGICAL AND IMMUNE STATUS IN THE PATIENTS WITH RHEUMATOID ARTHRITIS
per: T. Y. Abramova, et al.
Publicat: (2014-07-01)

Editorial: Risk factors for Rheumatoid Arthritis and pre-Rheumatoid Arthritis
per: Emillie Sapart, et al.
Publicat: (2022-12-01)

Results of cross-sectional epidemiologic study on determination of recombinant biological agents requirement for treatment of patients with rheumatoid arthritis in real-life clinical practice. Report 1. Demographic, social, clinicaland laboratory characteristics of Russian patients with rheumatoid arthritis
per: S F Erdes, et al.
Publicat: (2009-12-01)

Histoplasmosis infection in patients with rheumatoid arthritis, 1998-2009
per: Matteson Eric L, et al.
Publicat: (2011-05-01)

Unusual course of AA amiloidosis in a patient with rheumatoid arthritis
per: Y V Muravjev, et al.
Publicat: (2009-04-01)

Fabrication of a triptolide-loaded and poly-γ-glutamic acid-based amphiphilic nanoparticle for the treatment of rheumatoid arthritis
per: Zhang L, et al.
Publicat: (2018-04-01)